WASHINGTON, D.C. - A California federal judge properly construed a disputed patent term as narrowed by the doctrine of prosecution history disclaimer, a divided panel of the Federal Circuit U.S. Court of Appeals ruled April 16 (Biogen Idec Inc. and Genentech Inc. v. GlaxoSmithKline LLC, No. 12-1120, Fed. Cir.)....(read more)![]()
↧